List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 10.2. Medicines affecting coagulation |
Others observations: Therapeutic alternatives to be reviewed (2023) |
PAHO Strategic Fund Medicine List | 9.2. Medicines affecting coagulation | No observations |
WHO Model List of Essential Medicines (2021) | 10.2. Medicines affecting coagulation |
This medicine requires a children care specialist. Others observations: Therapeutic alternatives to be reviewed (2023). |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 10.2. Medicines affecting coagulation |
Others observations: Therapeutic alternatives to be reviewed (2023) |
PAHO Strategic Fund Medicine List | 9.2. Medicines affecting coagulation | No observations |
Cuba | 10.2 Modificadores de la coagulaciĆ³n | No observations |
WHO Model List of Essential Medicines (2021) | 10.2. Medicines affecting coagulation |
This medicine requires a children care specialist. Others observations: Therapeutic alternatives to be reviewed (2023) |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 10.2. Medicines affecting coagulation |
Others observations: Therapeutic alternatives to be reviewed (2023) |
PAHO Strategic Fund Medicine List | 9.2. Medicines affecting coagulation | No observations |
Peru | 10.2 Medications that Affect Coagulation | No observations |
Ecuador | Essential Medicines List - Ecuador | No observations |
Colombia | 12.2 Anticoagulants | No observations |
WHO Model List of Essential Medicines (2021) | 10.2. Medicines affecting coagulation |
This medicine requires a children care specialist. Others observations: Therapeutic alternatives to be reviewed (2023). |
List | Section | Observation |
---|---|---|
PAHO Strategic Fund Medicine List | 9.2. Medicines affecting coagulation | No observations |
WHO Model List of Essential Medicines (2021) | 10.2. Medicines affecting coagulation |
This medicine requires a children care specialist. Others observations: Therapeutic alternatives to be reviewed (2023). |
List | Section | Observation |
---|---|---|
Peru | 10.2 Medications that Affect Coagulation | No observations |
List | Section | Observation |
---|---|---|
Cuba | 10.2 Modificadores de la coagulaciĆ³n | No observations |
List | Section | Observation |
---|---|---|
Bolivia | LINAME 2011 - 2013 | No observations |